Tsuchiya Takayoshi, Oto Yuji, Ayabe Tadayuki, Obata Kazuo, Murakami Nobuyuki, Nagai Toshiro
Department of Pediatrics, Dokkyo Medical University Koshigaya Hospital, Saitama, Japan.
Clin Pediatr Endocrinol. 2011 Apr;20(2):33-8. doi: 10.1297/cpe.20.33. Epub 2011 Oct 7.
Prader-Willi syndrome (PWS) is frequently associated with marked obesity and diabetes mellitus (DM). Although the overall frequency of DM in PWS ranges from 7-20%, there is only limited data available on Japanese patients. This study evaluated five factors associated with DM in PWS: 1) frequency, 2) age of onset, 3) risk factors, 4) long-term complications and 5) treatment. Sixty-five patients, ranging in age from 10 to 53 yr, were studied retrospectively. The frequency of DM in patients over 10 yr of age was 26.2% (17/65 patients). The age of DM onset ranged from 10 to 29 yr with a median age of 15 yr. The body mass index (BMI) was significantly higher in the DM group in comparison with the non-DM group. The number of patients using growth hormone (GH) in the DM group was significantly lower than the number that did not. Proteinuria (urinary excretion of albumin/creatinine at spot collection: U-Alb/Cr ≥300 mg/gCr) was observed in 1/17 patients (5.9%), microalbuminuria (U-Alb/Cr 30-300 mg/gCr) was observed in 4/17 patients (23.5%) and nonproliferative retinopathy was observed in 2/17 patients (11.8%). Among oral hypoglycemic agents, alpha-glucosidase inhibitors (α-GI) were most often used in our patients (10/17, 58.8%). Eleven out of 17 patients (64.7%) had been treated with insulin.
普拉德-威利综合征(PWS)常伴有明显肥胖和糖尿病(DM)。尽管PWS中DM的总体发生率为7%-20%,但关于日本患者的数据有限。本研究评估了与PWS中DM相关的五个因素:1)发生率,2)发病年龄,3)危险因素,4)长期并发症和5)治疗。对65例年龄在10至53岁之间的患者进行了回顾性研究。10岁以上患者的DM发生率为26.2%(17/65例患者)。DM发病年龄为10至29岁,中位年龄为15岁。与非DM组相比,DM组的体重指数(BMI)显著更高。DM组使用生长激素(GH)的患者数量明显低于未使用的患者数量。1/17例患者(5.9%)出现蛋白尿(即时尿白蛋白/肌酐排泄率:U-Alb/Cr≥300mg/gCr),4/17例患者(23.5%)出现微量白蛋白尿(U-Alb/Cr 30-300mg/gCr),2/17例患者(11.8%)出现非增殖性视网膜病变。在口服降糖药中,α-葡萄糖苷酶抑制剂(α-GI)在我们的患者中使用最为频繁(10/17,58.8%)。17例患者中有11例(64.7%)接受了胰岛素治疗。